Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $11.1500 (-4.13%) ($11.1000 - $11.7400) on Mon. Apr. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.28% (three month average) | RSI | 69 | Latest Price | $11.1500(-4.13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.2% a day on average for past five trading days. | Weekly Trend | IOVA advances 8.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(48%) ARKG(47%) IWO(43%) ARKK(41%) | Factors Impacting IOVA price | IOVA will decline at least -2.14% in a week (0% probabilities). VXX(-13%) VIXM(-8%) UUP(-7%) IFRA(-5%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.14% (StdDev 4.28%) | Hourly BBV | 0 () | Intraday Trend | -4.8% | | | |
|
5 Day Moving Average | $11.5(-3.04%) | 10 Day Moving Average | $11.59(-3.8%) | 20 Day Moving Average | $10.7(4.21%) | To recent high | -11.8% | To recent low | 32.6% | Market Cap | $1.633b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |